# HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

> **NCT00145626** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 40 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Myelodysplasia
- Chronic Myeloid Leukemia
- Histiocytosis

## Interventions

- **DRUG:** Chemotherapy and antibodies
- **DEVICE:** Miltenyi Biotec CliniMACS
- **PROCEDURE:** Allogeneic stem cell transplantation

## Key facts

- **NCT ID:** NCT00145626
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2015-03
- **Final completion:** 2016-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145626, "HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00145626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*